Biolife Solutions
Open
$26.39
Prev. Close
$26.39
High
$26.39
Low
$26.25
Market Snapshot
$1.27B
-430.0
-0.44
$74.65M
155
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 155 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the cell and gene therapy market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal closed systems are purpose-built rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The firm's ThawSTAR product line comprises a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 155 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the cell and gene therapy market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal closed systems are purpose-built rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The firm's ThawSTAR product line comprises a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Recently from Cashu
Activist Investors Target Biolife Solutions, Seek Changes in Strategy and Governance
Biolife Solutions (Ticker: BLFS) is currently facing increased scrutiny from activist investors, as recent SEC filings indicate their active engagement with the company. This development is significan…
Biolife Solutions Reports Strong Q4 Growth Driven by Biopreservation and R&D Investments
Biolife Solutions Maintains Momentum in Biopreservation with Strong Q4 Performance Biolife Solutions continues to solidify its standing as a pivotal player in the biopreservation sector, showcasing re…
BioLife Solutions Advances Cell Culture Technology, Enhancing Competitive Edge in Biopreservation Market
BioLife Solutions Enhances Market Position Through Innovative Advancements in Cell Culture Technology BioLife Solutions is at the forefront of biopreservation and cell culture media, providing critica…
BioLife Solutions, Qkine partner on cytokine distribution and CellSeal Connect packaging
BioLife forges distribution and packaging tie-up with Qkine BioLife Solutions is expanding its presence in the cell and gene therapy (CGT) supply chain through a multi‑year agreement with Cambridge‑ba…